drugset / Trial / NCT00219869

Galantamine in the Treatment of Post-Traumatic Headache

NCT00219869

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).

Timeline

Start
2005-07
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Galantamine Small molecule